# Patent

## Title
Controlled adjustment of medicine dispensation from an infusion pump device

## Abstract

Some embodiments of an infusion pump system can incorporate an accelerometer or other motion sensor to detect the user's activity level. If the user's activity level indicates that he or she is exercising or otherwise at an elevated level, the infusion pump device can be configured to automatically adjust the dispensation rate of a medicine such as insulin. Accordingly, an insulin delivery rate can be corrected to account for a user's activity level (e.g., an elevated activity level during exercise or the like).

## Background
TECHNICAL FIELD
This document relates to a portable insulin infusion pump system having an accelerometer or other motion sensor to detect a user's activity level.
BACKGROUND
Pump devices are commonly used to deliver one or more fluids to a targeted individual. For example, a medical infusion pump device may be used to deliver a medicine to a patient as part of a medical treatment. The medicine that is delivered by the infusion pump device can depend on the condition of the patient and the desired treatment plan. For example, infusion pump devices have been used to deliver insulin to the vasculature of diabetes patients so as to regulate blood-glucose levels.
SUMMARY
Some embodiments of an infusion pump system can incorporate an accelerometer other motion sensor to detect the user's activity level. If the user's activity level indicates that he or she is exercising or otherwise at an elevated level, the infusion pump device can be configured to automatically adjust the dispensation rate of a medicine such as insulin. Accordingly, an insulin delivery rate can be corrected to account for a user's activity level (e.g., an elevated activity level during exercise or the like) without having to rely on the user's instruction to change the delivery rate.
In particular embodiments, a portable and wearable insulin pump system may include a disposable and non-reusable pump device having a drive system to dispense insulin. The pump device can define a space to receive an insulin cartridge. The system can also include a reusable controller device removably attached to the pump device. The controller device can have control circuitry that communicates control signals to the drive system to dispense insulin at a dispensation rate when the controller device removably attached to the pump device. The controller device can include an user interface. The system can also include an accelerometer arranged in the reusable controller and electrically connected to the control circuitry. The accelerometer can provide signals indicative of activity levels of the user. The controller device can automatically adjust the dispensation rate based at least in part on the signals of the accelerometer indicative of the activity levels of the user.
In some aspects, the controller device can automatically reduce a basal rate of insulin if signals of the accelerometer indicate an increased activity level. In other aspects, the controller device can automatically increase a basal rate of insulin if signals of the accelerometer indicate a decreased activity level. Furthermore, the automatic adjustment of insulin delivery can be based on an integration of detected activity levels over a recent period of time. The controller device can automatically adjust the dispensation rate without instructional input from the user. In such circumstances, the controller device can communicate to the user via the user interface when the dispensation rate is automatically adjusted (e.g., to notify the user of the automatic adjustment).
In some embodiment, a method of automatically adjusting insulin dispensed to a patient based on an activity level of the patient can include delivering insulin to a patient from an insulin pump system having disposable and non-reusable pump device having a drive system to dispense the insulin and a reusable controller device removably attached to the pump device. The controller device can including control circuitry communicating control signals to the drive system and a motion sensor (e.g., an accelerometer or the like) electrically connected to the control circuitry. The method can further include detecting movement activities of the user with the motion sensor of the controller device and automatically adjusting a dispensation rate of the insulin to the patient based at least in part on the detected movement activities of the user.
Some or all of the embodiments described herein may provide one or more of the following advantages. First, some embodiments of an infusion pump system may include an accelerometer other motion sensor, which can be used to detect the movement of the insulin infusion pump system. An estimate of an activity level of the user can be determined from the detected movement of the insulin infusion pump system, and a controller can automatically adjust the rate of insulin delivery based on the estimated activity level. This configuration may permit the controller to promptly and accurately adjust the insulin delivery without user input.
Second, some embodiments of the infusion pump system may include a reusable controller device that is removably attachable to a disposable single-use pump device to provide an electrical connection therebetween. In these circumstances, the infusion pump system can include an accelerometer (or other motion sensor) arranged in the reusable controller device such that the accelerometer is not discarded with the single-use pump device. Accordingly, the accelerometer can be employed in a cost-effective manner that permits reuse of the instrumentation with a series of different pump devices.
Third, some embodiments of the pump device may be attached to the controller device so that a user can readily monitor infusion pump operation by simply viewing the user interface connected to the pump device. In these circumstances, the user may activate and control the pump device without the requirement of locating and operating a separate monitoring module.
Fourth, some embodiments of the infusion pump system may be configured to be portable, wearable, and (in some circumstances) concealable. For example, a user can conveniently wear the infusion pump system on the user's skin under clothing or can carry the pump device in the user's pocket (or other portable location) while receiving the medicine dispensed from the pump device.
The details of one or more embodiments are set forth in the accompanying drawings and the description below. Other features, objects, and advantages will be apparent from the description and drawings, and from the claims.



DESCRIPTION OF DRAWINGS
FIG. 1 is a perspective view of an infusion pump system in accordance with some embodiments.
FIG. 2 is a perspective view of the infusion pump system of FIG. 1 in an assembled state.
FIG. 3 is another perspective view of the infusion pump system of FIG. 2.
FIG. 4 is a perspective view of the infusion pump system of FIG. 1 in a detached state.
FIG. 5 is another perspective view of the infusion pump system on FIG. 4.
FIG. 6 is a perspective view of an infusion pump system, in accordance with some embodiments.
FIG. 7 is a perspective view of the infusion pump system of FIG. 6 worn on clothing of a user.
FIG. 8 is a perspective view of an infusion pump system worn on skin of a user, in accordance with particular embodiments.
FIGS. 9-10 are perspective views of a pump device being detached from a controller device, in accordance with some embodiments.
FIGS. 11-12 are perspective views of the pump device of FIGS. 9-10 being discarded and the controller device of FIGS. 9-10 being reused with a new pump device.
FIGS. 13-14 are perspective views of the new pump device of FIG. 11 being attached to the controller device of FIG. 11.
FIG. 15 is an exploded perspective view of a controller device for an infusion pump system, in accordance with some embodiments.
FIG. 16 is an exploded perspective view of a pump device for an infusion pump system, in accordance with some embodiments.
FIG. 17 is a perspective view of a portion of the pump device of FIG. 16.
FIG. 18 is a top view of a portion of the pump device of FIG. 16.



DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS
Referring to FIGS. 1-3, an infusion pump system 10 can include a pump device 100 and a controller device 200 that can communicate with the pump device 100. The pump device 100 can include a housing structure 110 that defines a cavity 116 in which a fluid cartridge 120 can be received. The pump device 100 also can include a cap device 130 to retain the fluid cartridge 120 in the cavity 116 of the housing structure 110. The pump device 100 can include a drive system (described in more detail below) that advances a plunger 125 in the fluid cartridge 120 so as to dispense fluid therefrom. The controller device 200 can communicate with the pump device 100 to control the operation of the drive system. When the controller device 200, the pump device 100 (including the cap device 130), and the fluid cartridge 120 are assembled together, the user can (in some embodiments) conveniently wear the infusion pump system 10 on the user's skin under clothing or in the user's pocket while receiving the fluid dispensed from the pump device 100.
The controller device 200 may be configured as a reusable component that provides electronics and a user interface to control the operation of the pump device 100. In such circumstances, the pump device 100 can be a disposable component that is disposed of after a single use. For example, as described in more detail below in connection with FIGS. 9-14, the pump device 100 can be a “one time use” component that is thrown away after the fluid cartridge 120 therein is exhausted. Thereafter, the user can removably attach a new pump device 100′ (having a new medicine cartridge 120′) to the reusable controller device 200 for the dispensation of fluid from a new fluid cartridge 120′. Accordingly, the user is permitted to reuse the controller device 200 (which may include complex or valuable electronics) while disposing of the relatively low-cost pump device 100 after each use. Such a pump system 10 can provide enhanced user safety as a new pump device 100 (and drive system therein) is employed with each new fluid cartridge 120.
As shown in FIG. 1, the infusion pump system 10 may also incorporate an accelerometer 249 or other motion sensor that can detect physical movement characteristics of the user while the pump system 10 is in operation. As discussed in further detail below in connection with FIG. 15, the accelerometer 249 may detect the motion of the insulin infusion pump system 10 and communicate with the control circuitry 240 (FIG. 15) to record the sensor data in an activity log. In this embodiment, the accelerometer 249 is housed in the controller device 200 so that is can be reused with a series of disposable pump device 100. As such, the movement characteristics of the user can be detected and recorded while the pump system 10 (including the controller device 200) are carried or otherwise worn by the user.
Briefly, in use, the pump device 100 can be configured to be removably attach to the controller device 200 in a manner that provides a secure fitting, an overall compact size, and a reliable electrical connection that is resistant to water migration. For example, as described in more detail below in connection with FIGS. 1-5, the controller device 200 can include a housing 210 having a number of features that mate with complementary features of the pump housing 110. In such circumstances, the controller device 200 can be removably attached to the pump device 100 in a generally side-by-side configuration while not fully surrounding the pump housing 110. Accordingly, the pump device 100 and the controller device 200 can be separate components that fit together, but the overall size of the combined assembly can be reduced because there is no requirement for one component (e.g., the controller device) to completely surround or envelop the second component (e.g., the pump device). The compact size permits the infusion pump system 10 to be discrete and portable (as described below in connection with FIGS. 6-8). Moreover, at least one of the pump device 100 or the controller device 200 can include a release member that facilitates an easy-to-use detachment and replacement process.
Furthermore, in use, the controller device 200 or another portion of the pump system can include the accelerometer 249 or other motion sensor that detects physical movements of the user. This configuration may permit the controller device 200 to automatically adjust the amount of insulin delivered to the user. For example, the controller device 200 can automatically reduce the basal rate delivery to the user if signals of the accelerometer 249 indicate an increased activity level (e.g., due to the user exercising, participating in an athletic activity, or the like). In addition or in the alternative, the controller device 200 can be configured to automatically increase the basal rate delivery if signals of the accelerometer 249 indicate a decreased activity level (e.g., automatically reduce the daytime basal rate if low activity levels are detected). In some embodiments, the automatic adjustment of insulin delivery can be based on an integration of activity levels over a recent period of time (e.g., the activities detected over a period about 3 minutes to about 30 minutes, about 5 minutes to about 10 minutes, or the like).
Referring again to FIGS. 1-3, the pump system 10 can be a medical infusion pump system that is configured to controllably dispense a medicine from the cartridge 120. As such, the fluid cartridge 120 can contain a medicine 126 (FIG. 1) to be infused into the tissue or vasculature of a targeted individual, such as a human or animal patient. For example, the pump device 100 can be adapted to receive a medicine cartridge 120 in the form of a carpule that is preloaded with insulin or another medicine for use in the treatment of Diabetes (e.g., Byetta®, Symlin®, or others). Such a cartridge 120 may be supplied, for example, by Eli Lilly and Co. of Indianapolis, Ind. Other examples of medicines contained in the fluid cartridge 120 include: pain relief drugs, hormone therapy, blood pressure treatments, anti-emetics, osteoporosis treatments, or other injectable medicines. The fluid cartridge 120 may have other configurations. For example, the fluid cartridge may comprise a reservoir that is integral with the pump housing structure 110 (e.g., the fluid cartridge can be defined by one or more walls of the pump housing structure 110 that surround a plunger to define a reservoir in which the medicine is injected or otherwise received).
In some embodiments, the pump device 100 can include one or more structures that interfere with the removal of the medicine cartridge 120 after the medicine cartridge 120 is inserted into the cavity 116. For example, as shown in FIG. 1, the pump housing structure 110 can include one or more retainer wings 119 that at least partially extend into the cavity 116 to engage a portion of the medicine cartridge 120 when the medicine cartridge 120 is installed therein. Such a configuration may facilitate the “one-time-use” feature of the pump device 100. In some embodiments, the retainer wings 119 interfere with attempts to remove the medicine cartridge 120 from the pump device 100, thus ensuring that the pump device 100 will be discarded along with the medicine cartridge 120 after the medicine cartridge 120 is emptied, expired, or otherwise exhausted. Accordingly, the pump device 100 can operate in a tamper-resistant and safe manner because the pump device 100 can be designed with predetermined life expectancy (e.g., the “one-time-use” feature in which the pump device is discarded after the medicine cartridge 120 is emptied, expired, or otherwise exhausted).
Still referring to FIGS. 1-3, the controller device 200 can be removably attached to the pump device 100 so that the two components are mechanically mounted to one another in a fixed relationship. Such a mechanical mounting can form an electrical connection between the removable controller device 200 and the pump device 100. For example, the controller device 200 can be in electrical communication with a portion of a drive system (not shown in FIGS. 1-3) of the pump device 100. As described in more detail below, the pump device 100 can include a drive system that causes controlled dispensation of the medicine or other fluid from the cartridge 120. In some embodiments, the drive system incrementally advances a piston rod (not shown in FIGS. 1-3) longitudinally into the cartridge 120 so that the fluid is forced out of an output end 122. A septum 121 (FIG. 1) at the output end 122 of the fluid cartridge 120 can be pierced to permit fluid outflow when the cap device 130 is connected to the pump housing structure 110 (described in more detail below). Thus, when the pump device 100 and the controller device 200 are attached and thereby electrically connected, the controller device 200 can communicate electronic control signals via a hardwire-connection (e.g., electrical contacts or the like) to the drive system or other components of the pump device 100. In response to the electrical control signals from the controller device 200, the drive system of the pump device 100 causes medicine to incrementally dispense from the medicine cartridge 120.
As shown in FIG. 1, the pump device 100 can include an electrical connector 118 (e.g., having conductive pads, pins, and the like) that are exposed to the controller device 200 and that mate with a complementary electrical connector (refer to connector 218 in FIG. 4) on the adjacent face of the controller device 200. The electrical connectors 118 and 218 provide the electrical communication between the control circuitry (refer, for example, to FIG. 15) housed in the controller device 200 and at least a portion of the drive system or other components of the pump device 100. For example, in some embodiments, the electrical connectors 118 and 218 can permit the transmission of electrical control signals to the pump device 100 and the reception of feedback signals (e.g., sensor signals) from particular components within the pump device 100. Furthermore, as described in more detail below, the infusion pump system 10 can include a gasket 140 that provides a seal that is resistant to migration of external contaminants when the pump device 100 is attached to the controller device 200. Thus, in some embodiments, the infusion pump system 10 can be assembled into a water resistant configuration that protects the electrical interconnection from water migration (e.g., if the user encounters water while carrying the pump system 10).
Still referring to FIGS. 1-3, the controller device 200 can include a user interface 220 that permits a user to monitor the operation of the pump device 100. In some embodiments, the user interface 220 includes a display device 222 and one or more user-selectable buttons (e.g., four buttons 224a, 224b, 224c, and 224d in this embodiment). The display device 222 can include an active area in which numerals, text, symbols, images, or a combination thereof can be displayed (refer, for example, to FIG. 2). For example, the display device 222 can be used to communicate a number of settings or menu options for the infusion pump system 10. In this embodiment, the user may press one or more of the buttons 224a, 224b, 224c, and 224d to shuffle through a number of menus or program screens that show particular settings and data (e.g., review data that shows the medicine dispensing rate, the total amount of medicine dispensed in a given time period, the amount of medicine scheduled to be dispensed at a particular time or date, the approximate amount of medicine remaining in the cartridge 120, or the like). In some embodiments, the user can adjust the settings or otherwise program the controller device 200 by pressing one or more buttons 224a, 224b, 224c, and 224d of the user interface 220. For example, in embodiments of the infusion pump system 10 configured to dispense insulin, the user may press one or more of the buttons 224a, 224b, 224c, and 224d to change the dispensation rate of insulin or to request that a bolus of insulin be dispensed immediately or at a scheduled, later time. Also, the user can activate the illumination instrument 230 on the controller device 200 by pressing one or more buttons 224a, 224b, 224c, and 224d of the user interface 220.
Accordingly, when the controller device 200 is connected to the pump device 100, the user can be provided with the opportunity to readily monitor infusion pump operation by simply viewing the user interface 220 of the controller device 200 connected to the pump device 100. Such monitoring capabilities may provide comfort to a user who may have urgent questions about the current operation of the pump device 100. Also, in these embodiments, there may be no need for the user to carry and operate a separate module to monitor the operation of the infusion pump device 100, thereby simplifying the monitoring process and reducing the number of devices that must be carried by the user. If a need arises in which the user desires to monitor the operation of the pump device 100 or to adjust settings of the pump system 10 (e.g., to request a bolus amount of medicine), the user can readily operate the user interface 220 of the controller device 200, which is removably attached to the pump device 100, without the requirement of locating and operating a separate monitoring module.
Referring now to FIGS. 4-5, when the infusion pump system 10 operates, the controller device 200 can be removably attached to the pump device 100 in a side-by-side arrangement. For example, the pump device 100 may be moved in a longitudinal direction (e.g., refer to direction 219 in FIG. 13) toward the controller device 200 until the complementary features connect and secure the separate components in the side-by-side arrangement. In these circumstances, the pump device 100 and the controller device 200 can be separate components that fit together, but the overall size of the combined assembly can be reduced because there is no requirement for one component (e.g., the controller device or pump device) to surround or envelop the second component (e.g., the pump device or controller device). Moreover, in some embodiments, the pump device 100 and controller device 200 can be readily attached together with a “one-movement” process that is convenient to the user.
The controller device 200 can include a controller housing structure 210 having a number of features that are configured to mate with complementary features of the pump housing structure 110 so as to form a releasable mechanical connection. For example, the pump housing structure 110 can include a barrel 111 that mates with a complementary barrel channel 211 of the controller housing 210. Also, the pump housing 110 can include slider channel 112 that slidably engages a complementary rail 212 defined by the controller housing 210. The slider channel 112 can guide the relative motion between the pump device 100 and the controller device 200 in the longitudinal direction during the attachment process. Similarly, the pump housing 110 can include a segmented rail 114a-b (FIG. 1) that mates with a guide channel 214a-b to direct the relative longitudinal motion between the pump device 100 and the controller device 200. As described in more detail below, the segmented rails 114a-b can interact with the release member 215 so as to releasably secure the pump device 100 into assembly with the controller device 200. In addition, the pump housing 110 can include an extension 113 (FIG. 1) that mates with a depression 213 (FIG. 4) in the controller housing 210 when the pump device 100 is fully attached to the controller device 200. It should be understood that, in other embodiments, other features or connector devices can be used to facilitate the side-by-side mounting arrangement. These other features or connector devices can include, for example, magnetic attachment device, mating tongues and grooves, mounting protrusions that friction fit into mating cavities, or the like.
Still referring to FIGS. 4-5, the pump device 100 and the controller device 200 can be attached in a manner that is resistant to migration of external contaminants (e.g., water, dirt, and the like) both into the pump housing structure 110 and the controller housing structure 210. For example, when the pump device 100 is advanced in the longitudinal direction toward the controller device 200 (as guided by the slider channel 112 and the segmented rails 114a-b), the electrical connector 118 (FIG. 5) of the pump device 100 is directed toward engagement with the mating connector 218 (FIG. 4) of the controller device 200. When the connectors 118 and 218 join together to form the electrical connection, the gasket 140 is compressed between the adjacent surfaces of the pump housing 110 and the controller housing 210. The gasket 140 thereby forms a water-resistant seal between the ambient environment and the mated connectors 118 and 218. Accordingly, in particular circumstances, the infusion pump system 10 can be assembled into a “water tight” configuration that protects sensitive internal components from water migration in the event that the user encounters water while wearing the pump system 10. In one example, the gasket 140 can resist migration of water to the electrical connectors 118 and 218 even when the system 10 is submerged underwater (e.g., in a pool, in a bath, or the like) for an extended period of time, such as at least 10 minutes, at least 30 minutes, at least one hour, at least two hours, and preferably at least four hours.
In addition, other paths for migration of external contaminants into the assembled pump system 10 can be sealed. For example, the infusion pump system 10 can include one or more seals that are arranged to hinder migration of external contaminants between the cap device 130 and the pump housing 110 into the cavity 116 of the pump device 100. In some embodiments, the seal 131 arranged between the cap device 130 and the barrel 111 can provide an effective water-resistant seal against water migration into the cavity. As such, the medicine cartridge 120 and pump drive system (not shown in FIGS. 4-5) can be protected during operation.
Still referring to FIGS. 4-5, some embodiments of the infusion pump system 10 may employ a power source arranged in pump device 100 or the controller device 200 that draws upon surrounding air for optimum operation. Because the controller device 200 and the pump device 100 may be sealed to resist water migration during normal usage, a water-resistant vent instrument 145 can be used to provide the air to the power source without permitting migration of water therethrough. For example, the pump device 100 can contain a first power source 345 in the form of a zinc-air cell battery (refer to FIG. 16), which draws upon the surrounding air during operation. When the pump device 100 is in use, the pump housing 110 can be sealed to protect the internal drive system and medicine cartridge from water migration. As such, the pump housing 110 can include a water-resistant vent instrument 145 disposed proximate to the first power source 345 (e.g., a zinc air cell battery) so that some air may pass through the vent 145 and toward the first power source 345. The water-resistant vent instrument 145 can include one or more layers of a material that is permeable to air and resistant to passage of liquids such as water. For example, the water-resistant vent instrument 145 can include one or more layers of a GORE-TEX material to resist the migration of water into the pump device while permitting the passage of air toward the battery.
Accordingly, the pump device 100 and the controller device 200 can be mounted to one another so that the assembled system 10 is resistant to water migration both into the pump housing structure 110 and the controller housing structure 210. Such a configuration can also provide water-resistant protection for the electrical connection between the pump device 100 and the controller 200. Thus, the sensitive internal components in the controller device 200 and the pump device 100 can be reliably protected from water migration if the user encounters water (e.g., rain, incidental splashing, and the like) while using the pump system 10.
Referring to FIGS. 6-8, the infusion pump system 10 can be configured to be portable and can be wearable and concealable. For example, a user can conveniently wear the infusion pump system 10 on the user's skin (e.g., skin adhesive) underneath the user's clothing or wear the pump device 100 in the user's pocket (or other portable location) while receiving the medicine dispensed from the pump device 100. As described below in connection with FIGS. 16-18, the drive system of the pump device 100 can be arranged in a compact manner so that the pump device 100 has a reduced length. For example, in the circumstances in which the medicine cartridge 120 has a length of about 6 cm to about 7 cm (about 6.4 cm in one embodiment), the overall length of the pump housing structure 110 (which contains medicine cartridge and the drive system) can be about 7 cm to about 10 cm and about 7 cm to about 9 cm (about 8.3 cm or less in some embodiments). In addition, the pump housing structure 110 can have an overall height of about 2 cm to about 4 cm (about 3.1 cm or less in some embodiments) and an overall thickness of about 8 mm to about 20 mm (about 17.5 mm or less in one embodiment).
The pump system 10 is shown in FIG. 6 as being held in a user's hand 5 so as to illustrate an exemplary size of the system 10 in accordance with some embodiments. This embodiment of the infusion pump system 10 is compact so that the user can wear the portable infusion pump system 10 (e.g., in the user's pocket, connected to a belt clip, adhered to the user's skin, or the like) without the need for carrying and operating a separate module. In such embodiments, the cap device 130 of the pump device 100 can be configured to mate with an infusion set 146. In general, the infusion set 146 can be a tubing system that connects the infusion pump system 10 to the tissue or vasculature of the user (e.g., to deliver medicine into the tissue or vasculature under the user's skin). The infusion set 146 can include a flexible tube 147 that extends from the pump device 100 to a subcutaneous cannula 149 retained by a skin adhesive patch 148 that secures the subcutaneous cannula 149 to the infusion site. The skin adhesive patch 148 can retain the infusion cannula 149 in fluid communication with the tissue or vasculature of the patient so that the medicine dispensed through the tube 147 passes through the cannula 149 and into the user's body. The cap device 130 can provide fluid communication between the output end 122 (FIG. 1) of the medicine cartridge 120 and the tube 147 of the infusion set 146.
Referring to FIG. 7, in some embodiments, the infusion pump system 10 can be pocket-sized so that the pump device 100 and controller device 200 can be worn in the user's pocket 6 or in another portion of the user's clothing. In some circumstances, the user may desire to wear the pump system 10 in a more discrete manner. Accordingly, the user can pass the tube 147 from the pocket 6, under the user's clothing, and to the infusion site where the adhesive patch 148 can be positioned. As such, the pump system 10 can be used to delivery medicine to the tissues or vasculature of the user in a portable, concealable, and discrete manner.
Referring to FIG. 8, in some embodiments, the infusion pump system 10 can be configured to adhere to the user's skin 7 directly at the location in which the skin is penetrated for medicine infusion. For example, a rear surface 102 (FIG. 3) of the pump device 100 can include a skin adhesive patch so that the pump device 100 can be physically adhered to the skin of the user at a particular location. In these embodiments, the cap device 130 can have a configuration in which medicine passes directly from the cap device 130 into an infusion cannula 149 that is penetrated into the user's skin. In some examples, the user can temporarily detach the controller device 200 (while the pump device 100 remains adhered to the skin 7) so as to view and interact with the user interface 220.
Referring now to FIGS. 9-14, the infusion pump system 10 can be operated such that the pump device 100 is a disposable, non-reusable component while the controller device 200 is a reusable component. In these circumstances, the pump device 100 may be configured as a “one-time-use” device that is discarded after the medicine cartridge is emptied, expired, or otherwise exhausted. Thus, in some embodiments, the pump device 100 can be designed to have an expected operational life of about 1 day to about 30 days, about 1 day to about 20 days, about 1 to about 14 days, or about 1 day to about 7 days—depending on the volume of medicine in the cartridge 120, the dispensation patterns that are selected for the individual user, and other factors. For example, a medicine cartridge 120 containing insulin can have an expected usage life about 7 days after the cartridge is removed from a refrigerated state and the septum 121 is punctured. In some circumstances, the dispensation pattern selected by the user can cause the insulin to be emptied from the medicine cartridge 120 before the 7-day period. If the insulin is not emptied from the medicine cartridge 120 after the 7-day period, the remaining insulin can become expired sometime thereafter. In either case, the pump device 100 and the medicine cartridge 120 therein can be discarded after exhaustion of the medicine cartridge 120 (e.g., after being emptied, expired, or otherwise not available for use).
The controller device 200, however, may be reused with subsequent new pump devices 100′ and new medicine cartridges 120′. As such, the control circuitry, the user interface components, and other components that may have relatively higher manufacturing costs can be reused over a longer period of time. For example, in some embodiments, the controller device 200 can be designed to have an expected operational life of about 1 year to about 7 years, about 2 years to about 6 years, or about 3 years to about 5 years—depending on a number of factors including the usage conditions for the individual user. Accordingly, the user can be permitted to reuse the controller device 200 (which can include complex or valuable electronics) while disposing of the relatively low-cost pump device 100 after each use. Such a pump system 10 can provide enhanced user safety as a new pump device 100′ (and drive system therein) is employed with each new fluid cartridge 120.
Referring to FIGS. 11-12, the same controller device 200 can be reused with a new pump device 100′ having a new medicine cartridge 120′ retained therein, and the previously used pump device 100 can be discarded with the exhausted medicine cartridge 120. The new pump device 100′ (FIG. 11) can have a similar appearance, form factor, and operation as the previously used pump device 100 (FIGS. 9-10 and 12), and thus the new pump device 100′ can be readily attached to the controller device 200 for controlled dispensation of medicine from the new medicine cartridge 120′. In some embodiments, the user can prepare the new pump device 100 for use with the controller device 200. For example, the user may insert the new medicine cartridge 120′ in the cavity 116 of the new pump device 100′ and then join the cap device 130 to the pump housing to retain the new medicine cartridge 120′ therein (refer, for example, to FIG. 1). Although the tubing 147 of the infusion set 146 is not shown in FIG. 11, it should be understood that the tubing 147 can be attached to the cap device 130 prior to the cap device 130 being joined with the housing 110. For example, a new infusion set 146 can be connected to the cap device 130 so that the tubing 147 can be primed (e.g., a selected function of the pump device 100 controlled by the controller 200) before attaching the infusion set patch to the user's skin. As shown in FIG. 11, the new medicine cartridge 120′ may be filled with medicine such that the plunger 125 is not viewable through the barrel 111.
Referring to FIGS. 13-14, the new pump device 100′ can be removably attached to the controller device 200 to assemble into the infusion pump system 10 for delivery of medicine to the user. Before the pump device 100 is electrically connected with the controller device 200, the user may prepare the new pump device 100′ for use by pulling the removable tab 141 away from the pump housing 110. The new pump device 100′ can include the removable tab 141 to seal the battery in the unused pump device 100′ and thereby maintain the battery in a storage mode (refer, for example, to FIG. 12 in which the removable tab 141 is arranged to cover an internal face of the vent 115). As described in more detail below, when the new pump device 100′ is prepared for usage, the removable tab 141 can be pulled away from the pump housing 110 (and away from the battery therein), which switches the battery into an activation mode. Thus, the shelf-life of the pump device 100′ (prior to usage with the controller device 200) may be extended by sealing the battery in a storage mode because little, if any, energy is dissipated from the battery when in the storage mode.
The guided motion in the longitudinal direction 219 provides the user with a convenient “one-movement” process to attach the pump device 100′ and the controller device 200. For example, the user can readily slide the pump device 100′ and the controller device 200 toward one another in a single movement (e.g., in the longitudinal direction) that causes both a physical connection and an electrical connection. Thus, the infusion pump system 10 can permit users to readily join the pump device 100′ and the controller device 200 without compound or otherwise difficult hand movements—a feature that can be beneficial to child users or to elderly users.
Referring now to FIG. 15, the controller device 200 (shown in an exploded view) houses a number of components that can be reused with a series of successive pump devices 100. In particular, the controller device 200 includes control circuitry 240 arranged in the controller housing 210 that is configured to communicate control signals to the drive system of the pump device 100. In this embodiment, the control circuitry 240 includes a main processor board 242 that is in communication with a power supply board 244. The control circuitry 240 includes at least one processor 243 that coordinates the electrical communication to and from the controller device 200 (e.g., communication between the controller device 200 and the pump device 100). The processor 243 can be arranged on the main processor board 242 along with a number of other electrical components such as memory devices. It should be understood that, although the main processor board 242 is depicted as a printed circuit board, the main processor board can have other forms, including multiple boards, a flexible circuit substrate, and other configurations that permit the processor 243 to operate. The control circuitry 240 can be programmable in that the user may provide one or more instructions to adjust a number of settings for the operation of the infusion pump system 10. Such settings may be stored in the memory devices arranged in the control circuitry 240. Furthermore, the control circuitry 240 may include one or more dedicated memory devices that store executable software instructions for the processor 243.
The control circuitry 240 may include other components, such as sensors, that are electrically connected to the main processor board 242. In one example of a sensor, the accelerometer 249 or other motion sensor can be electrically connected to the main processor board 242 so as to communicate movement characteristics data to the processor 243 or other components of the control circuitry 240. The accelerometer 249 can be configured to surface mount to the main processor board 242. Alternatively, the accelerometer 249 can be incorporated with the controller device 200 at another position so that the accelerometer 249 is connected with the control circuitry via a wired connection, a flexible circuit connection, or the like.
Still referring to FIG. 15, in some embodiments, the accelerometer 249 or other motion sensor can be used to detect movement characteristics such as the acceleration of the pump system 10 (e.g., while worn by the user), the vibrations of the pump system 10, or a combination thereof. This movement characteristic information can be processed by the control circuitry 240 of the controller device 200 for purposes of altering an insulin delivery rate. When a period of elevated activity level (e.g., exercise by the user) is sensed, the controller device 200 can be configured to automatically adjust the insulin delivery rate without further instructions from the user. As such, when the user begins to participate in an elevated activity such as exercise or an athletic event, the user may have confidence that the controller device 200 can account for this change in physical activity by adjusting the insulin delivery rate accordingly. When the insulin deliver rate is automatically adjusted, the control device 200 can inform the user of the dosage change by an audible tone or a visual indication (refer, for example, to the display device 222 of FIG. 1).
Still referring to FIG. 15, the controller device 200 can be electrically connected with the pump device 100 via mating connectors 118 and 218 (FIGS. 4-5) so that the control circuitry 240 can communicate control signals to the pump device 100 and receive feedback signals from components housed in the pump device 100. In this embodiment, the electrical connector 118 (FIG. 5) on the pump device 100 is a z-axis connector, and the connector 218 (FIG. 4) on the controller device 200 is adapted to mate therewith. The electrical connector 218 on the controller device 200 is in communication with the control circuitry 240. As such, the processor 243 can operate according to software instructions stored in the memory device so as to send control signals to the pump device 100 via the connector 218.
Also as previously described, the controller device 200 can include the illumination instrument 230 that may be operated by the controller circuitry 240. For example, the illumination instrument 230 can include an LED device 232 that is electrically activated by the control circuitry 240 according to the user's input or according to the previously described automated conditions. The light emitted from the LED device 232 can be transmitted through a light guide 234 arranged on the external face of the controller housing 210. It should be understood that, in other embodiments, the illumination instrument 230 may include other light source configurations.
Still referring to FIG. 15, the user interface 220 of the controller device 200 can include input components, output components, or both that are electrically connected to the control circuitry 240. For example, in this embodiment, the user interface 220 includes a display device 222 having an active area that outputs information to a user and four buttons 224a-d that receive input from the user. Here, the display 222 may be used to communicate a number of settings or menu options for the infusion pump system 10. In this embodiment, the control circuitry 240 may receive the input commands from the user's button selections and thereby cause the display device 222 to output a number of menus or program screens that show particular settings and data (e.g., review data that shows the medicine dispensing rate, the total amount of medicine dispensed in a given time period, the amount of medicine scheduled to be dispensed at a particular time or date, the approximate amount of medicine remaining the cartridge 120, or the like). As previously described, the controller circuit 240 can be programmable in that the input commands from the button selections can cause the controller circuit 240 to change any one of a number of settings for the infusion pump system 100.
Some embodiments of the control circuitry 240 may include a cable connector (e.g., a USB connection port or another data cable port) that is accessible on an external portion of the controller housing 210. As such, a cable may be connected to the control circuitry 240 to upload data or program settings to the controller circuit or to download data from the control circuitry 240. For example, historical data of medicine delivery can be downloaded from the control circuitry 240 (via the cable connector) to a computer system of a physician or a user for purposes of analysis and program adjustments. Optionally, the data cable may also provide recharging power.
Referring to FIGS. 15-16, the infusion pump system 10 can have two power sources 345 (FIG. 16) and 245 (FIG. 15) that cooperate to power the infusion pump system 10. For example, in some embodiments, the pump device 100 can include a first power source 345 (refer to FIG. 16) capable of transmitting electrical energy to the controller device 200 when the pump device 100 is attached to the controller device 200. The control circuitry 240 of the controller device 200 can include a second power source 245, which can be coupled to the power supply board 244 of the control circuitry 240. The second power source 245 can include a high current-output battery that is capable of discharging a brief current burst to power, for example, a drive system (Refer to FIG. 16) of the pump device 100 and is capable of accepting and storing electrical energy over time and (e.g., “trickle charge”). The hard-wired transmission of electrical energy from the power source 245 to the drive system 300 can occur through the previously described connectors 118 and 218 (FIGS. 4-5). The second power source 245 can receive electrical energy from a power source housed in the pump device 100 (e.g., the first power source 345), from a plug-in wall charger, from a cable connector (e.g., a USB connection port that is connected to the control circuitry 240), or from another charging device (e.g., a charging cradle).
Accordingly, the infusion pump system 10 can have two power sources 345 and 245—one arranged in the disposable pump device 100 and another arranged in the reusable controller device 200—which can permit a user to continually operate the controller device 200 without having to recharge a battery via a plug-in wall charger or other cable. Because the controller device 200 can be reusable with a number of pump devices 100 (e.g., attach the new pump device 100′ after the previous pump device 100 is expended and disposed), the second power source 245 in the controller device can be recharged over a period of time, each time when a new pump device 100 is connected thereto. Such a configuration can be advantageous in those embodiments where the pump device 100 is configured to be a disposable, one-time-use device that attaches to a reusable controller device 200. For example, in those embodiments, the “disposable” pump devices 100 recharge the second power source 245 in the “reusable” controller device 200, thereby reducing or possibly eliminating the need for separate recharging of the controller device 200 via a power cord plugged into a wall outlet.
Referring now to FIGS. 16-18, the pump device 100 may include a drive system 300 that is controlled by the removable controller device 200 (FIGS. 1-5). Accordingly, the drive system 300 can accurately and incrementally dispense fluid from the pump device 100 in a controlled manner. The drive system 300 may include a flexible piston rod 370 that is incrementally advanced toward the medicine cartridge 120 so as to dispense the medicine from the pump device 100. At least a portion of the drive system 300 is mounted, in this embodiment, to the pump housing 110. In this embodiment, the pump housing 110 includes a chassis 107, a shell portion 108, and a cover mount 109. The shell portion 108 can be used to cover at least a portion of the drive system 300. For example, the shell 108 may include an inner curved surface against which a curved section of a piston rod 370 rests. The cover mount 109 may be assembled to the chassis 107 of the pump housing 110 to secure some components of the drive system 300 in position between the cover mount 109 and the chassis 107. When the cover mount 109 is assembled into place, the “unused” or retracted portion of the piston rod 370 may rest in a channel defined in the top of the cover mount 109. The shell portion 108 can slide over the cover mount 109 and join with the chassis 107 to form the assembled pump housing 110.
Some embodiments of the drive system 300 may include a battery powered actuator (e.g., reversible motor 320 or the like) that resets a ratchet mechanism 330, a spring device 350 (FIG. 18) that provides the driving force to the ratchet mechanism 330, and a drive wheel 360 that is rotated by the ratchet mechanism 330 to advance the flexible piston rod 370 toward the medicine cartridge 120. The operation of the drive system 300 is described in commonly assigned U.S. patent application Ser. No. 11/677,706, which was filed on Feb. 22, 2007 and is incorporated herein by reference.
As shown in FIGS. 17-18, the pump device 100 can include one or more motion detectors coupled with the drive system 300 to provide feedback regarding the operation of the drive system 300. For example, the pump device 100 may include a first motion detector 302 configured as a limit switch that detects when a portion of the ratchet mechanism has reached the limit of its travel and must thereafter stop movement or reverse direction. The operation of the limit switch 302 is described in previously incorporated U.S. patent application Ser. No. 11/677,706. In another example, the pump device 100 may include a second motion detector 307 in the form of a mechanical error switch that indicates whether components of the drive system 300 completed the desired motion for each drive cycle. The operation of the mechanical error switch 307 is also described in more detail in U.S. patent application Ser. No. 11/677,706.
Referring to FIGS. 17-18, the pump device 100 includes a connector circuit 310 to facilitate the transfer of signals to and from the electrical connector 118. As previously described, the electrical connector 118 of the pump device 100 mates with the connector 218 (FIG. 4) of the controller device 200 so that electrical communication can occur between the pump device 100 and the controller device 200. The connector circuit 310 may comprise a generally non-complex circuit 310 that does not include a processor or other relatively high-cost components. In this embodiment, the connector circuit 310 operates as a passageway for the control signals (from the control circuitry 240 (FIG. 15) of the controller device 200) to transmit to the drive system 300 (e.g., to the actuator 320). For example, the reversible motor 320 may be connected to the connector circuit 310 via one or more wires 304. The connector circuit 310 also operates as a passageway for the electrical power from the first battery 345 (FIG. 17) to pass to the controller device 200 for recharging of the second battery 245 (FIG. 15). For example, the first battery 345 may be connected to the connector circuit 310 via one or more power contacts 305. Furthermore, the connector circuit 310 operates as a passageway for feedback signals (e.g., from the motion detectors 302 and 307) to transmit to the control circuitry 240 (FIG. 15) of the controller device 200. For example, the limit switch 302 may be connected to the connector circuit 310 via one or more wires 306 (the one or more wires connecting the mechanical error switch 307 to the connector circuit 310 are not shown in FIGS. 17-18).
In some embodiments, the connector circuit 310 in the pump device 100 includes a memory device 318 that can store data regarding the pump device 100 and its operational history. For example, the memory device 318 of the connector circuit 310 may include a flash memory chip that is configured to store data such as: a unique serial number designated for the pump device 100, a manufacturer identifier code, and a drive cycle counter. The unique serial number designated for the pump device 100 and the manufacturer identifier code may be useful pieces of quality control information that remains with the pump device 100 throughout its shelf-life and operational life. If, for example, a manufacturing error is identified for a particular pump device 100, the unique serial number and the manufacturer identifier code (e.g., a lot code) can be used to promptly identify the manufacturing location and its manufacturing lot.
The drive cycle counter stored in the memory device 318 can be useful for maintaining an accurate estimate of the volume of medicine that remains in the medicine cartridge 120. For example, the number of drive cycles that are required to incrementally advance the plunger 125 and thereby dispense a full medicine cartridge 120 may be a predetermined value (e.g., in some embodiments, 6,300 drive cycles result in full dispensation of a new medicine cartridge). Accordingly, the drive cycle counter stored in the memory device 318 can keep track of the number of drive cycles that have occurred through the operational life of the pump device 100. Each time the motor 320 completes a new drive cycle and incrementally advances the piston rod 370 to dispense some medicine, the controller device 200 can store an updated value for the drive cycle counter stored in the memory device 318. When the updated value stored in drive cycle counter stored in the memory device 318 approaches the predetermined value, the controller device 200 can alert the user that the medicine cartridge is approaching exhaustion. Furthermore, because the memory device 318 is arranged in the pump device 100, the drive cycle counter stored in the memory device 318 remains local to the pump device 100. If the pump device 100 is temporarily disconnected from the controller device 200 and then reconnected (or reconnected to a different controller device 200), the controller device 200 can retrieve the value for the drive cycle counter stored in the memory device 318 and promptly ascertain how much medicine remains in the medicine cartridge 120.
Still referring to FIGS. 17-18, in some embodiments, the flexible piston rod 370 comprises a plurality of segments 372 serially connected by hinge portions 373 so that the flexible piston rod 370 is adjustable from a curved shape to a noncurved shape. The plurality of segments 372 and the interconnecting hinge portions 373 can be integrally formed in one piece from one or more moldable materials, including polymer materials such as Nylon or POM. In this embodiment, each of the plurality of rod segments 372 includes an exterior thread pattern 374 along at least one cylindrical surface portion. The piston rod 370 also includes a plunger engagement device 375 can be arranged at a forward end of the piston rod 370. As such, the plunger engagement device 375 faces toward the medicine cartridge 120 when the medicine cartridge 120 is inserted into the cavity 116. In some embodiments, the plunger engagement device 375 may comprise a pusher disc that abuts against the plunger 125 of the medicine cartridge 120 (FIG. 1).
Turning now to the operation of the accelerometer 249 (FIGS. 1 and 15) for the infusion pump system 10, the accelerometer can be used to collect real-time data related to the user's physical activity for the purpose of modifying the medicine dispensation rate to the user. For example, in the case of a diabetic user receive insulin infusion from the pump system 10, certain levels of exercise can increase the insulin efficiency, which effectively reduces the need for insulin during (and sometimes after) the period exercise. Furthermore, the user's exercise can also activate non-insulin mediated glucose transport pathways, which may increase effective insulin efficiency. As such, the user's blood glucose levels can fall when the muscles demand more glucose (e.g., during exercise), when the insulin becomes more efficient in the blood, or a combination thereof. In particular circumstances, this reduction in blood glucose levels can lead to hypoglycemia. Accordingly, the accelerometer of the infusion pump system can be used to automatically adjust the insulin dispensation accordingly.
A number of embodiments have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of this disclosure. Accordingly, other embodiments are within the scope of the following claims.

## Claims

1. A portable and wearable insulin pump system, comprising:
a disposable and non-reusable pump device having a drive system to dispense insulin, the pump device including: a pump housing that defines a space to receive an insulin cartridge, a cap device that connects with the pump housing to enclose the insulin cartridge in the pump housing when the insulin cartridge is received in the space, and a retainer structure that is different from the cap device and that extends into the space to engage a portion of the medicine cartridge and thereby hinder removal of the insulin cartridge when the insulin cartridge is received in the space such that the insulin cartridge is non-removable from the disposable and non-reusable pump device;
a reusable controller device removably attached to the pump device and being different from the cap device of the pump device, the controller device including: a controller housing matable with the pump housing structure to form a releasable mechanical connection, control circuitry positioned in the controller housing that electrically transmits control signals to the drive system positioned in the pump housing to dispense insulin at a dispensation rate when the controller device is removably attached to the pump device, the controller device including a user interface; and
an accelerometer arranged in controller housing of the reusable controller device and electrically connected to the control circuitry such that the accelerometer is external to the pump housing of the pump device, the accelerometer providing signals indicative of activity levels of the user;
wherein the controller device automatically adjusts the dispensation rate based at least in part on the signals of the accelerometer indicative of the activity levels of the user, and
wherein the controller device automatically reduces a basal rate of insulin if signals of the accelerometer indicate an increased activity level.

2. The system of claim 1, wherein the controller device automatically increases a basal rate of insulin if signals of the accelerometer indicate a decreased activity level.

3. The system of claim 1, wherein the retainer structure that is different from the cap device comprises one or more retainer wings that engaged the insulin cartridge when the insulin cartridge is received in the space.

4. The system of claim 3, wherein the one or more retainer wings hinder removal of the insulin cartridge and prevent reuse of the pump device with a new insulin cartridge when the insulin cartridge is received in the space.

5. The system of claim 4, wherein the one or more retainer wings engaged a neck portion of the insulin cartridge when the insulin cartridge is received in the space.

6. The system of claim 1, wherein the insulin cartridge and the pump device with a new insulin cartridge are a one-time-use apparatus when the insulin cartridge is received in the space.

7. The system of claim 1, wherein the cap device that connects with the pump housing pierces a septum of the insulin cartridge when the insulin cartridge is received in the space defined by the pump housing.

8. The system of claim 7, wherein the cap device seals the insulin cartridge in the space defined by the pump housing when the insulin cartridge is received in the space defined by the pump housing.

9. The system of claim 8, wherein the cap device is configured to mate with an infusion set having a flexible tube and a subcutaneous cannula.

10. The system of claim 9, further comprising a ring seal member between the cap device and the pump housing.

11. The system of claim 1, wherein the disposable and non-reusable pump device comprises a first disposable and non-reusable pump device, the system further comprising a second disposable and non-reusable pump device that is similar in shape and size to first disposable and non-reusable pump device, wherein the second disposable and non-reusable pump device is removably attachable to the reusable controller device when the first disposable and non-reusable pump device is detached and discarded.

12. The system of claim 11, wherein the disposable and non-reusable pump device is a single-use device that is discarded with the insulin cartridge after exhaustion of the insulin cartridge.

13. The system of claim 12, wherein user interface of the controller device includes a single display device that is the only display device of the system.

14. The system of claim 1, wherein the automatic adjustment of insulin delivery is based on an integration of detected activity levels over a recent period of about 3 minutes to about 30 minutes.

15. The system of claim 1, wherein the pump device includes a first electrical connector along an exterior face of the pump housing, and the controller device includes a second electrical connector along an exterior face of the controller housing that opposes the exterior face of the pump housing, and wherein the first and second electrical connectors provide electrical communication between the control circuitry positioned in the controller housing and an electrically powered mechanical actuator of the drive system positioned in the pump housing.

16. The system of claim 15, wherein the control circuitry positioned in the controller housing electrically transmits control signals directly to the electrically powered mechanical actuator of the drive system to dispense insulin at the dispensation rate when the controller device is removably attached to the pump device.

17. The system of claim 1, wherein when the reusable controller device is removably attached to the disposable and non-reusable pump device, the system is sized to be worn in a clothing pocket while dispensing insulin.

18. The system of claim 1, wherein when the reusable controller device is removably attached to the disposable and non-reusable pump device, the system is sized to be adhered to a skin surface while dispensing insulin.

19. The system of claim 1, wherein the accelerometer is mounted to a main processor board of the control circuitry positioned in the controller housing such that the accelerometer is positioned external to the pump housing that contains the drive system and the space to receive the insulin cartridge.

20. The system of claim 19, wherein the control circuitry positioned in the controller housing includes a processor while the disposable and non-reusable pump device is free of a processor.

21. The system of claim 20, wherein the disposable and non-reusable pump device includes a connector circuit that operates as passageway for control signals transmitted from the control circuitry positioned in the controller housing to the actuator of the drive system positioned in the pump housing.

22. The system of claim 20, wherein the control circuitry positioned in the controller housing is electrically connected to user interface components mounted to the controller housing while the disposable and non-reusable pump device is free of user interface components.

23. The system of claim 1, wherein the pump housing contains a first power source and the controller housing contains a second power source that is different from the first power source.

24. The system of claim 1, wherein the pump housing defines the space to receive the insulin cartridge as a cavity that extends in a longitudinal direction inside the pump housing.

25. The system of claim 24, wherein the pump device is removably attached to the controller device by guided movement of the pump device relative to the controller device in the longitudinal direction.

26. The system of claim 1, further comprising a second disposable and non-reusable pump device having a shape similar to the first disposable and non-reusable pump device, and the second disposable and non-reusable pump device defining a space to receive a second insulin cartridge.

27. The system of claim 26, wherein the second disposable and non-reusable pump device is removably attachable to the reusable controller device in a fixed relationship when the first disposable and non-reusable pump device is removed from the reusable controller device, the control circuitry of the reusable controller device communicating control signals to a drive system of the second disposable and non-reusable pump device when the reusable controller device is removably attached to the second disposable and non-reusable pump device.

28. The system of claim 27, wherein the reusable controller device automatically reduces a basal rate of insulin dispensed from the second disposable and non-reusable pump device if signals of the accelerometer indicate an increased activity level.

29. The system of claim 28, wherein the controller device automatically increases a basal rate of insulin dispensed from the second disposable and non-reusable pump device if signals of the accelerometer indicate a decreased activity level.

30. The system of claim 1, wherein the controller device automatically adjusts the dispensation rate of insulin dispensed from the disposable and non-reusable pump device without instructional user input.

31. The system of claim 30, wherein the controller device communicates to the user via the user interface when the dispensation rate of insulin dispensed from the disposable and non-reusable pump device is automatically adjusted.

32. A portable and wearable insulin pump system, comprising:
a disposable and non-reusable pump device having a drive system to dispense insulin, the pump device including: a pump housing that defines a space to receive an insulin cartridge, and a cap device that connects with the pump housing to enclose the insulin cartridge in the pump housing when the insulin cartridge is received in the space;
a reusable controller device removably attached to the pump device and being different from the cap device of the pump device, the controller device including: a controller housing matable with the pump housing structure to form a releasable mechanical connection, control circuitry positioned in the controller housing that communicates control signals to the drive system to dispense insulin at a dispensation rate when the controller device is removably attached to the pump device, the controller device including a user interface; and
an accelerometer arranged in the controller housing of the reusable controller device and electrically connected to the control circuitry, the accelerometer providing signals indicative of activity levels of the user;
wherein the controller device automatically adjusts the dispensation rate based at least in part on the signals of the accelerometer indicative of the activity levels of the user,
wherein the automatic adjustment of insulin delivery is based on an integration of detected activity levels over a recent period of about 3 minutes to about 30 minutes.

33. The system of claim 32, wherein the controller device automatically adjusts the dispensation rate without instructional input from the user.

34. The system of claim 32, wherein the controller device communicates to the user via the user interface when the dispensation rate is automatically adjusted.

35. The system of claim 34, wherein the user interface comprises a display device and one or more buttons for actuation by the user.

36. The system of claim 35, wherein the controller device communicates to the user via the display device to notify the user that the dispensation rate was automatically adjusted.

37. The system of claim 32, wherein the disposable and non-reusable pump device includes a retainer structure that is different from the cap device and that extends into the space to engage a portion of the medicine cartridge and thereby hinder removal of the insulin cartridge when the insulin cartridge is received in the space such that the insulin cartridge is non-removable from the disposable and non-reusable pump device.

38. The system of claim 32, wherein the retainer structure that is different from the cap device comprises one or more retainer wings that engaged the insulin cartridge when the insulin cartridge is received in the space.

39. The system of claim 38, wherein the one or more retainer wings hinder removal of the insulin cartridge and prevent reuse of the pump device with a new insulin cartridge when the insulin cartridge is received in the space.

40. The system of claim 39, wherein the one or more retainer wings engaged a neck portion of the insulin cartridge when the insulin cartridge is received in the space.

41. The system of claim 32, wherein the cap device that connects with the pump housing pierces a septum of the insulin cartridge when the insulin cartridge is received in the space defined by the pump housing.

42. The system of claim 41, wherein the cap device seals the insulin cartridge in the space defined by the pump housing when the insulin cartridge is received in the space defined by the pump housing.

43. The system of claim 42, wherein the cap device is configured to mate with an infusion set having a flexible tube and a subcutaneous cannula.

44. The system of claim 43, further comprising a ring seal member between the cap device and the pump housing.

45. The system of claim 32, wherein the disposable and non-reusable pump device comprises a first disposable and non-reusable pump device, the system further comprising a second disposable and non-reusable pump device that is similar in shape and size to first disposable and non-reusable pump device, wherein the second disposable and non-reusable pump device is removably attachable to the reusable controller device when the first disposable and non-reusable pump device is detached and discarded.

46. The system of claim 45, wherein the disposable and non-reusable pump device is a single-use device that is discarded with the insulin cartridge after exhaustion of the insulin cartridge.

47. The system of claim 46, wherein user interface of the controller device includes a single display device that is the only display device of the system.

48. The system of claim 32, wherein the pump device includes a first electrical connector along an exterior face of the pump housing, and the controller device includes a second electrical connector along an exterior face of the controller housing that opposes the exterior face of the pump housing, and wherein the first and second electrical connectors provide electrical communication between the control circuitry positioned in the controller housing and an electrically powered mechanical actuator of the drive system positioned in the pump housing.

49. The system of claim 48, wherein the control circuitry positioned in the controller housing electrically transmits control signals directly to the electrically powered mechanical actuator of the drive system to dispense insulin at the dispensation rate when the controller device is removably attached to the pump device.

50. The system of claim 32, wherein when the reusable controller device is removably attached to the disposable and non-reusable pump device, the system is sized to be worn in a clothing pocket while dispensing insulin.

51. The system of claim 32, wherein when the reusable controller device is removably attached to the disposable and non-reusable pump device, the system is sized to be adhered to a skin surface while dispensing insulin.

52. The system of claim 32, wherein the accelerometer is mounted to a main processor board of the control circuitry positioned in the controller housing such that the accelerometer is positioned external to the pump housing that contains the drive system and the space to receive the insulin cartridge.

53. The system of claim 52, wherein the control circuitry positioned in the controller housing includes a processor while the disposable and non-reusable pump device is free of a processor.

54. The system of claim 53, wherein the disposable and non-reusable pump device includes a connector circuit that operates as passageway for control signals transmitted from the control circuitry positioned in the controller housing to the actuator of the drive system positioned in the pump housing.

55. The system of claim 54, wherein the control circuitry positioned in the controller housing is electrically connected to user interface components mounted to the controller housing while the disposable and non-reusable pump device is free of user interface components.